Pfizer Inc

PFE: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
@q#LOCK|$khHLOCK|d<ZC^Q

Pfizer Earnings: Expected Sales Decline Met With Solid Bottom-Line Growth From Cost Savings

Pfizer's $13.7 billion in revenue (an 8% decline) and adjusted diluted EPS of $0.92 (12% growth) allowed the firm to maintain its full-year guidance of $61 billion-$64 billion in revenue and $2.80-$3.00 in adjusted diluted EPS, which does not include a placeholder for potential new tariffs.

Sponsor Center